Washington Homeopathic Products Occular Allergy Blend fails identification testing
Washington Homeopathic Products is recalling Occular Allergy Blend 87% Alcohol (Lot # 30148, 500 mL bottles) distributed nationwide due to out-of-specification test results in identification testing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves out-of-specification test results with no reported illnesses or injuries mentioned in the source. The hazard is quality/identity-related rather than a direct safety threat with documented harm.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Occular Allergy Blend 87% Alcohol, a homeopathic medicine for manufacturing use only. The product is supplied in 500 mL bottles and was distributed nationwide in the USA.
The recall was initiated due to out-of-specification test results obtained for identification testing based on HPTLC (high-performance thin-layer chromatography) analysis. This means the product did not meet specifications in laboratory testing used to verify its identity.
The affected product is Lot # 30148. Consumers or distributors who have received this product should stop using it and contact Washington Homeopathic Products, Inc. for instructions on return or disposal.
The recalled product
- Product
- Occular Allergy Blend 87% Alcohol; In Equal Parts of Apis Mellifica 7x Allium Cepa 7x Euphrasia Officinalis 7X Sabadilla 7X, WHP Homeopathic Medicine For Manufacturing Only, 500 ml. Manufcatured by Washington Homeopathic Products 260JR Hawvermale Way, Berkeley Springs WV 25411
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic Medicine
- Hazard
- out-of-specification-identity
- failed-testing
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot # 30148
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27